Skip to content

Author

U. Neumann

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Curative Versus Non-Curative First Recurrence After Surgical Resection for Hepatocellular Carcinoma: Determinants, Patterns, and Clinical Impact.

BACKGROUND Recurrence after curative-intent resection for hepatocellular carcinoma (HCC) is common. Not all recurrences are clinically equivalent, as some remain amenable to curative treatment. AIMS This study aimed to evaluate the clinical impact of curatively versus noncuratively treatable first recurrence on postr...

A. Mantas, S. Lueong, Marlene Dropmann et al. · 0 citations
Review Open access Oct 2026

The future of pediatric renal transplantation with machine perfusion technology at the frontier.

Renal transplantation is the only curative treatment approach for children with end-stage kidney disease, ensuring the best possible growth, neurocognitive and social development. However, the field of pediatric kidney transplantation is highly heterogeneous with different indications, timing, graft types, institutiona...

Khurshed Nabiev, F. Schliephake, Robert Oellinger et al. · 0 citations
Open access Sep 2026

Real-world survival benefit of adding durvalumab to chemotherapy in cholangiocarcinoma: a retrospective cohort analysis from a German Comprehensive Cancer Centre

Background Advanced biliary tract cancers (BTCs) carry a poor prognosis. Gemcitabine/platinum chemotherapy was the first-line standard until TOPAZ-1 and KEYNOTE-966 established immune checkpoint inhibitor-based combinations as a new standard. Real-world data with a chemotherapy-only comparator remain limited. Patients...

S. Elbasan, S. Kasper, I. Mavroeidi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.